Chronic marijuana (MRJ) use is associated with altered cognition and mood state, altered brain metabolites, and functional and structural brain changes. The objective of this study was to apply proton magnetic resonance spectroscopic imaging (MRSI) to compare proton metabolite levels in 15 young men with MRJ dependence and 11 healthy non-using (NU) young men. Spectra were acquired at 4.0 Tesla using 2D J-resolved MRSI to resolve coupled resonances in J-space and to quantify the entire J-coupled spectral surface of metabolites from voxels containing basal ganglia and thalamus, temporal and parietal lobes, and occipital white and gray matter. This method permitted investigation of high-quality spectra for regression analyses to examine metabolites relative to tissue type. Distribution of myo-inositol (mI)/creatine (Cr) was altered in the MRJ group whereas the NU group exhibited higher mI/Cr in WM than GM, this pattern was not observed in MRJ subjects. Significant relationships observed between global mI/Cr and distribution in WM, and selfreported impulsivity and mood symptoms were also unique between MRJ and NU groups. These preliminary findings suggest that mI, and distribution of this glial metabolite in WM, is altered by MRJ use and is associated with behavioral and affective features reported by young MRJ-dependent men.
Introduction
Cannabis, or marijuana (MRJ), is the most widely used illicit drug in the US, with 3.9 million people using MRJ almost daily in 2008 (SAMHSA, 2009) . The highest rate of MRJ use occurs in 18-25 year olds (16.5%), followed by 16-17 year olds (12.7%), 14-15 year olds (5.7%), and then those 26 years and older (4.2%). Not only is MRJ most commonly the first illicit substance used, with 2.2 million people becoming new MRJ users in 2008, equating to roughly 6000 initiates per day, but 61.8% of the recent initiates were 18 or younger. Further, MRJ has the highest rate for illicit drug dependence, accounting for 60.1% of all illicit drug abuse, and was the second highest substance for which treatment was received (for alcohol, 2.7 million persons and for MRJ, 947,000 persons reporting receiving treatment in 2008). Importantly, sex differences in individuals 12 years of age and older have been reported both for prevalence of past month MRJ use, with males reporting greater use (7.9%) than females (4.4%), and higher rates of dependence (males 11.5% versus females 6.4%).
Neuropsychological studies have shown deficits in attention, mental flexibility, learning and memory in MRJ-users (Block and Ghoneim, 1993; Bolla et al., 2002; Fletcher et al., 1996; Pope and Yurgelun-Todd, 1996; Pope et al., 2001; Solowij et al., 2002) , some of which persist even after drug use has ceased (Pope and Yurgelun-Todd, 1996; Pope et al., 2001 ). In addition to cognitive alterations, greater levels of impulsivity and depressive symptoms have been associated with MRJ use (Degenhardt et al., 2003; Ramaekers et al., 2006) . Although the neurobiological effects of MRJ have not been fully characterized, neuroimaging studies have shown that MRJ-users exhibit abnormal brain activation during performance of functional imaging tasks, including verbal list learning (Block et al., 2002; Bolla et al., 2005; Chang and Chronicle, 2007; Chang et al., 2006b) , decision-making (Iowa Gambling task) (Bolla et al., 2005 ), visual-attention (Chang et al., 2006b , and response inhibition (Gruber and Yurgelun-Todd, 2005 ) (for review, see Chang and Chronicle, 2007) . Altered activation may be related to reductions in grey matter (GM) volume in regions such as the medial temporal lobe (MTL) (Matochik et al., 2005; Yucel et al., 2008) (see also Block et al., 2000; Tzilos et al., 2005) , which has a high density of cannabinoid receptors (CB 1 ) (Iversen, 2003; Sullivan, 2000) . Cerebral
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